Assembly Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Assembly Biosciences, Inc.‘s stocks are currently a part of 19 hedge funds’ portfolios, which represents 8.18% of the total amount of its stocks outstanding. This makes up a total of 3.96M shares of Assembly Biosciences, Inc.. Compared to the previous quarter, the number fell by -72.09% or -10.23M shares fewer. As for the holding position changes, 21.05% (4) of current hedge fund investors increased the number of shares held, 47.37% (9) of current holders sold a part of the shares held, and 15.79% (3) closed the holdings completely. 1 hedge funds are new holders of Assembly Biosciences, Inc. stock in Q1 2023, it is 5.26% of total holders.
Hedge funds holding Assembly Biosciences (Q2 2018 – Q1 2023)
| Q2 2018 | 104 |
|---|---|
| Q3 2018 | 112 |
| Q4 2018 | 106 |
| Q1 2019 | 100 |
| Q2 2019 | 105 |
| Q3 2019 | 97 |
| Q4 2019 | 99 |
| Q1 2020 | 96 |
| Q2 2020 | 104 |
| Q3 2020 | 116 |
| Q4 2020 | 107 |
| Q1 2021 | 105 |
| Q2 2021 | 88 |
| Q3 2021 | 61 |
| Q4 2021 | 58 |
| Q1 2022 | 52 |
| Q2 2022 | 53 |
| Q3 2022 | 48 |
| Q4 2022 | 39 |
| Q1 2023 | 19 |
Hedge funds changes in Assembly Biosciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 17 | 46 | 31 | 19 | -9 |
|---|---|---|---|---|---|
| Q3 2018 | 23 | 58 | 21 | 15 | -5 |
| Q4 2018 | 18 | 35 | 39 | 24 | -10 |
| Q1 2019 | 8 | 41 | 30 | 14 | 7 |
| Q2 2019 | 30 | 40 | 20 | 23 | -8 |
| Q3 2019 | 11 | 31 | 37 | 19 | -1 |
| Q4 2019 | 22 | 42 | 25 | 20 | -10 |
| Q1 2020 | 13 | 40 | 31 | 15 | -3 |
| Q2 2020 | 16 | 49 | 23 | 9 | 7 |
| Q3 2020 | 22 | 32 | 44 | 10 | 8 |
| Q4 2020 | 28 | 39 | 24 | 38 | -22 |
| Q1 2021 | 15 | 37 | 33 | 16 | 4 |
| Q2 2021 | 14 | 29 | 35 | 31 | -21 |
| Q3 2021 | 3 | 25 | 23 | 30 | -20 |
| Q4 2021 | 9 | 20 | 17 | 12 | 0 |
| Q1 2022 | 11 | 11 | 18 | 17 | -5 |
| Q2 2022 | 7 | 12 | 21 | 6 | 7 |
| Q3 2022 | 3 | 10 | 21 | 9 | 5 |
| Q4 2022 | 2 | 10 | 20 | 11 | -4 |
| Q1 2023 | 1 | 4 | 9 | 3 | 2 |
Hedge funds changes in Assembly Biosciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 12,677,000 | 4,235,000 |
|---|---|---|
| Q3 2018 | 12,279,000 | 2,901,000 |
| Q4 2018 | 238,000 | 337,000 |
| Q1 2019 | 3,946,000 | 833,000 |
| Q2 2019 | 7,679,000 | 17,000 |
| Q3 2019 | 5,484,000 | 126,000 |
| Q4 2019 | 5,193,000 | 4,659,000 |
| Q1 2020 | 3,394,000 | 4,166,000 |
| Q2 2020 | 542,000 | 0 |
| Q3 2020 | 830,000 | 0 |
| Q4 2020 | 749,000 | 202,000 |
| Q1 2021 | 550,000 | 493,000 |
| Q2 2021 | 1,174,000 | 1,493,000 |
| Q3 2021 | 875,000 | 1,042,000 |
| Q4 2021 | 68,000 | 89,000 |
| Q1 2022 | 99,000 | 1,000 |
| Q2 2022 | 167,000 | 1,000 |
| Q3 2022 | 47,000 | 0 |
| Q4 2022 | 25,270 | 0 |
| Q1 2023 | 30,422,000 | 0 |